Metformin disappoints in two phase 2 lung cancer trials
Pediatric News ,
Although well tolerated, metformin does not improve survival when given alongside chemoradiotherapy to patients with locally…
Metformin Disappoints in Two Phase 2 Lung Cancer Trials
Medscape,
Although well tolerated, metformin does not improve survival when given alongside chemoradiotherapy to patients with locally…
Combination of metformin and chemoradiation does not add survival benefit in patients with LA-NSCLC
The Medical News,
A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not…
Adding metformin to chemoradiation for locally advanced non-small cell lung cancer doesn't yield survival benefits
MedicalXpress,
Credit: Pixabay/CC0 Public Domain A combination of metformin and chemoradiation in patients with locally advanced non-small…
Survival benefits not seen with addition of metformin to concurrent chemoradiation
Mirage News,
NRG Oncology Philadelphia, PA – A combination of metformin and chemoradiation in patients with locally advanced non-small cell…
Add-on metformin fails to improve locally advanced NSCLC outcomes
medwireNews,
medwireNews: Nondiabetic patients with stage III non-small-cell lung cancer (NSCLC) do not benefit from the addition of…
Neues zur Hormontherapie bei Brust- und Prostatakrebs; Metformin bei Lungenkrebs
Medscape,
Im Onko-Blog dieser Woche geht es um die optimale Therapiedauer einer adjuvanten Antihormontherapie beim Mammakarzinom und um…
Metformin No Silver Bullet in Locally Advanced NSCLC
MedPage Today,
Oncology/Hematology > Lung Cancer Adding diabetes agent to chemoradiotherapy failed to produce desired effects Using metformin…